NFKB1 and arthritic joint disease: (‐)-epicatechin-3-O-β-D-allopyranoside (ECAP), a glycoside, could effectively inhibit inflammatory pain and adjuvant-induced arthritis, which might be related to the inhibition of NF-κB pathway activation (Hsiao et al., 2019).